Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Vaxxas
Vaxxas
Activities:
Drug Delivery
Pharmaceutical
Dosage Forms
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Australian researchers use Nanopatch to deliver polio vaccine
About 40-times less polio vaccine needed using patch delivery compared with a needle and syringe
Drug Delivery
Vaxxas raises AS$25m to accelerate commercialisation of novel vaccine platform
Will advance a series of clinical programmes and develop a pipeline of new vaccine products for major diseases
Research & Development
Vaxxas research project aims to advance next-generation technology for polio vaccine delivery
World Health Organisation to fund the project
Drug Delivery
Vaxxas agrees Nanopatch collaboration with Merck
To develop the vaccine delivery technology for infection and oncology applications
Drug Delivery
Vaxxas appoints David Hoey as chief executive
Establishes operations in Boston, Massachusetts, US to expand access to global partners
Subscribe now